Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tailored Treatment of Hepatitis C Genotype 1
NCT00910975Phase 4Completed
- Sponsor
- University of Gothenburg
- Start
- Nov 2007
- Primary completion
- Jun 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a, ribavirin in hepatitis C (HCV), sponsored by University of Gothenburg. Started Nov 2007; status: completed.
02
Drugs
peginterferon alfa-2aribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00910975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910975.